Disclosures for "Real-world Tolerability of Foslevodopa/Foscarbidopa Subcutaneous Infusion in Parkinson’s Disease: Discontinuation Beyond Titration"
-
Ms. Rukavina has received research support from European Academy of Neurology .
-
Prof. Ebersbach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Prof. Ebersbach has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL.
-
Dr. Gruber has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AbbVie. Dr. Gruber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott.